2016-08-29 15:54:38 UTC

Aug. 30, 2016

In a new blog post, Dr. Evan S. Dellon highlights the marked need for better treatment options for EoE patients.

The first randomized clinical trial in eosinophilic esophagitis (EoE), which assessed the efficacy of swallowed fluticasone, had results published in 2006. Since that time, there have been a number of additional published trial results using topical steroids, biologic agents and novel small molecules. Currently, there are nearly 40 ongoing clinical trials listed on clinicaltrials.gov that are being conducted both in academia and by industry, including the first phase III trial in EoE.

In a blog post on Applied Clinical Trials, Evan S. Dellon, MD, MPH, discusses the reasons behind this tremendous increase in clinical trial activity, as well as the remaining treatment gaps. He also shares his personal experience with clinical trials related EoE.

This blog post is part of a new series in Applied Clinical Trials on drug development in GI, sponsored by the AGA Center for Diagnostics and Therapeutics.

Does this topic interest you? Join the center for its first Drug Development Conference, Oct. 27 and 28, 2016, in Washington, DC. In addition to EoE, the meeting will focus on drug development in GERD, gastroparesis and functional dyspepsia. Learn more and reserve your spot today.

More on Dyspepsia / Non-Ulcer Dyspepsia